Riyadh
Saudi Arabia · 1 retained evidence mentions
Source-grounded findings
Supporting evidence
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| population | Saudi Arabia, Riyadh | “HLA Class I and II Variants as Potential Determinants of Clinical Severity and Mortality in Patients with COVID-19: A Prospective Study from Saudi Arabia. This study aimed to determine the genotype frequency of HLA Class I and Class II loci in patients with COVID-19 in Saudi Arabia and to examine their associations with survival and clinical severity. Methods: A prospective observational study was conducted at King Faisal Specialist Hospital and Research Centre (KFSH&RC), Riyadh, Saudi Arabia, from January 2022 to December 2023. Results: In total, 123 patients with COVID-19 were included; 102 (82.9%) recovered and 21 (17.1%) died. Conclusions: Selected HLA Class I and Class II allele groups may be associated with COVID-19 survival and clinical severity patterns in this Saudi cohort.” | 0.95 | saudi_context_rules_v1 |